Created in 2017, CYPRIO is based on more than ten years of research and development at the School of Industrial Physics and Chemistry in Paris (ESPCI) and has solid expertise in the fields of biomaterial physicochemistry, liver biology and drug screening. This makes Cyprio the holder of a unique technology (BioPearl) for fabrication of spheroids that are
physiologically more relevant than traditional monolayer models and are compatible with high throughput screening applications.